EP3648787
TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.7.2018:
30.10.2024:
18746457.3
:
8.7.2038
:
TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF
9.7.2018
30.10.2024
:
Takeda Pharmaceutical Company Limited:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
:
CHAPMAN, Miranda:
Wellesley, MA 02482, US
:
EWENSTEIN, Bruce:
Brookline, MA 02445, US
:
PLODER, Bettina:
1220 Vienna, AT
:
201762530024 P:
7.7.2017:
US
:
201762546999 P:
17.8.2017:
US
:
US2018041319:
9.7.2018
:
A61K 38/36, A61P 7/04